Protein Design And Engineering Market Report 2026

Protein Design And Engineering Market Overview

• Protein Design And Engineering market size has reached to $7.62 billion in 2025 • Expected to grow to $15.71 billion in 2030 at a compound annual growth rate (CAGR) of 15.6% • Growth Driver: The Increasing Focus On Biologics Is Fueling Market Growth Due To High Demand For Targeted Therapies • Market Trend: AI Foundation Models Transform Protein Discovery And Accelerate Drug Development • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Protein Design And Engineering Market?

Protein design and engineering refers to the process of creating new proteins or modifying existing ones to achieve specific structural or functional properties. It combines principles from biology, chemistry, and computational modeling to predict and optimize how amino acid sequences fold and behave. This field is widely used to develop novel enzymes, therapeutics, and biomaterials with improved performance and targeted functions. The main types of protein design and engineering include rational designing, directed evolution, and semi rational designing. Rational designing refers to computational and structure-based approaches used to design proteins with desired functions and stability. These methods are applied across protein types including antibodies, peptides, enzymes, structural proteins, and others. The various applications involved are therapeutics, diagnostics, enzyme engineering, industrial biologics, and research use, and they are used by several end users such as pharma or biotech firms, contract research organizations, and academic institutes.

What Is The Protein Design And Engineering Market Growth Forecast?

The protein design and engineering market size is expected to see rapid growth in the next few years. It will grow to $15.71 billion in 2030 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to growth in AI driven drug discovery platforms, increasing demand for personalized therapeutics, expansion of synthetic biology applications, rising funding for precision medicine research, growing use of high performance computing in protein modeling. Major trends in the forecast period include rising adoption of AI driven protein structure prediction platforms for faster drug discovery, increasing use of computational modeling to design novel enzymes with improved catalytic efficiency, growing demand for de novo protein engineering in therapeutic development, expansion of synthetic biology approaches for customized biomaterials and biologics, rising integration of high throughput screening technologies in protein optimization workflows.

Global Protein Design And Engineering Market Segmentation

1) By Type: Rational Designing, Directed Evolution, Semi Rational Designing 2) By Protein Type: Antibodies, Peptides, Enzymes, Structural Proteins, Other Protein Types 3) By Application: Therapeutics, Diagnostics, Enzyme Engineering, Industrial Biologics, Research Use 4) By End User: Pharma Or Biotech Firms, Contract Research Organizations, Academic Institutes Subsegments: 1) By Rational Designing: Structure Based Design, Sequence Based Design, Computational Protein Design, De Novo Protein Design 2) By Directed Evolution: Random Mutagenesis, Site Specific Mutagenesis, Gene Shuffling, High Throughput Screening 3) By Semi Rational Designing: Focused Mutagenesis, Saturation Mutagenesis, Structure Guided Mutagenesis, Iterative Mutagenesis

What Is The Driver Of The Protein Design And Engineering Market?

The increasing focus on biologics is expected to propel the growth of the protein design and engineering market going forward. Biologics are therapeutic products derived from living organisms or their components that target specific pathways in the immune system to treat diseases. The emphasis on biologics is growing due to advancements in biotechnology and immunology, which have enabled the development of more precise and effective treatments that target the underlying mechanisms of immune-mediated conditions rather than merely managing symptoms. Protein design and engineering advances biologics by enabling the precise creation and optimization of therapeutic proteins with improved stability, efficacy, and target specificity, thereby accelerating the development of safer and more effective biologic drugs. For instance, in February 2025, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, the 2023 WHO Essential Medicines List includes 81 biologic therapies, representing over 15% of all listed medicines. Therefore, the increasing focus on biologics is driving the growth of protein design and engineering industry.

Key Players In The Global Protein Design And Engineering Market

Major companies operating in the protein design and engineering market are Merck KGaA, Eurofins Scientific SE, Lonza Group AG, DeepMind Technologies Limited, GenScript Biotech Corporation, Twist Bioscience Corporation, Ginkgo Bioworks Holdings Inc., Schrödinger Inc., Codexis Inc., Isomorphic Labs Limited, Generate Biomedicines Inc., Absci Corporation, Insilico Medicine Inc., EvolutionaryScale Inc., Latent Labs Inc., Telesis Bio Inc., Synbio Technologies LLC, Cradle Bio B.V., Arzeda Corporation, ProteinQure Inc., A-Alpha Bio Inc., DenovAI Biotech GmbH, Innophore GmbH

Global Protein Design And Engineering Market Trends and Insights

Major companies operating in the protein design and engineering market are focusing on developing innovative solutions, such as biological AI foundation models to accelerate the design of novel proteins, improve prediction of structure function relationships, and speed up drug discovery and bioengineering applications. A biological AI foundation model is a large-scale artificial intelligence system trained on vast biological data (such as DNA, RNA, and protein sequences) that can learn general biological patterns and be adapted to perform tasks like protein design, structure prediction, and drug discovery. For instance, in June 2024, EvolutionaryScale PBC, a US-based artificial intelligence biotechnology company, launched ESM3, an AI model capable of generating novel proteins to accelerate drug discovery, protein design, and biological research. The model leverages advanced generative AI to design and generate novel protein sequences with desired structures and functions. It is positioned as a technology-driven solution to accelerate protein discovery, enabling researchers to create entirely new proteins more efficiently. The platform supports streamlined protein engineering workflows by integrating sequence generation with structural prediction, reflecting the company’s focus on advancing AI-driven biological design.

What Are Latest Mergers And Acquisitions In The Protein Design And Engineering Market?

In June 2024, Johnson And Johnson, a US-based healthcare corporation, acquired Proteologix for $850 million. With this acquisition, Johnson & Johnson aims to strengthen its portfolio of engineered biologics and expand its capabilities in next-generation bispecific antibody therapeutics for immune-mediated diseases. Proteologix Inc. is a US-based company specializing in protein engineering-related biologics development.

Regional Outlook

North America was the largest region in the protein design and engineering market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Protein Design And Engineering Market?

The protein design and engineering market includes revenues earned by entities by providing services such as protein design using computational modeling, protein synthesis, expression services, and therapeutic protein development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Protein Design And Engineering Market Report 2026?

The protein design and engineering market research report is one of a series of new reports from The Business Research Company that provides protein design and engineering market statistics, including protein design and engineering industry global market size, regional shares, competitors with a protein design and engineering market share, detailed protein design and engineering market segments, market trends and opportunities, and any further data you may need to thrive in the protein design and engineering industry. This protein design and engineering market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.